To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
Public ClinicalTrials.gov record NCT02649075. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease
Study identification
- NCT ID
- NCT02649075
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Entera Health, Inc
- Industry
- Enrollment
- 7 participants
Conditions and interventions
Conditions
Interventions
- Placebo Other
- Serum-derived Bovine Immunoglobulin / Protein Isolate Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2016
- Primary completion
- Jul 31, 2017
- Completion
- Jul 31, 2017
- Last update posted
- Oct 3, 2017
2016 – 2017
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Little Rock | North Little Rock | Arkansas | 72117 | — |
| Hollywood | Hollywood | Florida | 30021 | — |
| Winter Park | Winter Park | Florida | 32789 | — |
| Hagerstown | Hagerstown | Maryland | 21742 | — |
| Manhattan | New York | New York | 10021 | — |
| Manhattan | New York | New York | 10028 | — |
| Cincinnati | Cincinnati | Ohio | 45219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02649075, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 3, 2017 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02649075 live on ClinicalTrials.gov.